BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11531933)

  • 1. Possible association but no linkage of the HSD11B2 gene encoding the kidney isozyme of 11beta-hydroxysteroid dehydrogenase to hypertension in Black people.
    White PC; Agarwal AK; Li A; Nikkila H; Pratt JH; Caulfield M; Clark A; McTernan C; Stewart PM
    Clin Endocrinol (Oxf); 2001 Aug; 55(2):249-52. PubMed ID: 11531933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic association of 11 beta-hydroxysteroid dehydrogenase type 2 (HSD11B2) flanking microsatellites with essential hypertension in blacks.
    Watson B; Bergman SM; Myracle A; Callen DF; Acton RT; Warnock DG
    Hypertension; 1996 Sep; 28(3):478-82. PubMed ID: 8794836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CA-Repeat polymorphism in intron 1 of HSD11B2 : effects on gene expression and salt sensitivity.
    Agarwal AK; Giacchetti G; Lavery G; Nikkila H; Palermo M; Ricketts M; McTernan C; Bianchi G; Manunta P; Strazzullo P; Mantero F; White PC; Stewart PM
    Hypertension; 2000 Aug; 36(2):187-94. PubMed ID: 10948076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype-phenotype correlations of mutations and polymorphisms in HSD11B2, the gene encoding the kidney isozyme of 11beta-hydroxysteroid dehydrogenase.
    White PC; Agarwal AK; Nunez BS; Giacchetti G; Mantero F; Stewart PM
    Endocr Res; 2000 Nov; 26(4):771-80. PubMed ID: 11196453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association studies between the HSD11B2 gene (encoding human 11beta-hydroxysteroid dehydrogenase type 2), type 1 diabetes mellitus and diabetic nephropathy.
    Lavery GG; McTernan CL; Bain SC; Chowdhury TA; Hewison M; Stewart PM
    Eur J Endocrinol; 2002 Apr; 146(4):553-8. PubMed ID: 11916625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of HSD11B2 polymorphisms in essential hypertension and the diuretic response to thiazides.
    Williams TA; Mulatero P; Filigheddu F; Troffa C; Milan A; Argiolas G; Parpaglia PP; Veglio F; Glorioso N
    Kidney Int; 2005 Feb; 67(2):631-7. PubMed ID: 15673310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural analysis and evaluation of the 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) gene in human essential hypertension.
    Brand E; Kato N; Chatelain N; Krozowski ZS; Jeunemaitre X; Corvol P; Plouin PF; Cambien F; Pascoe L; Soubrier F
    J Hypertens; 1998 Nov; 16(11):1627-33. PubMed ID: 9856363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late-onset apparent mineralocorticoid excess caused by novel compound heterozygous mutations in the HSD11B2 gene.
    Lavery GG; Ronconi V; Draper N; Rabbitt EH; Lyons V; Chapman KE; Walker EA; McTernan CL; Giacchetti G; Mantero F; Seckl JR; Edwards CR; Connell JM; Hewison M; Stewart PM
    Hypertension; 2003 Aug; 42(2):123-9. PubMed ID: 12860834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association studies between microsatellite markers within the gene encoding human 11beta-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism.
    Draper N; Echwald SM; Lavery GG; Walker EA; Fraser R; Davies E; Sørensen TI; Astrup A; Adamski J; Hewison M; Connell JM; Pedersen O; Stewart PM
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4984-90. PubMed ID: 12414862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the 11beta-hydroxysteroid dehydrogenase type 2 gene (HSD11B2) in human essential hypertension.
    Mariniello B; Ronconi V; Sardu C; Pagliericcio A; Galletti F; Strazzullo P; Palermo M; Boscaro M; Stewart PM; Mantero F; Giacchetti G
    Am J Hypertens; 2005 Aug; 18(8):1091-8. PubMed ID: 16109323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the 11beta-hydroxysteroid dehydrogenase type 2 in blood pressure regulation.
    Ferrari P; Krozowski Z
    Kidney Int; 2000 Apr; 57(4):1374-81. PubMed ID: 10760070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HSD11B2 CA-repeat and sodium balance.
    Mune T; Morita H; Takada N; Yamamoto Y; Isomura Y; Suwa T; Takeda J; White PC; Kaku K
    Hypertens Res; 2013 Jul; 36(7):614-9. PubMed ID: 23446772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutants of 11beta-hydroxysteroid dehydrogenase (11-HSD2) with partial activity: improved correlations between genotype and biochemical phenotype in apparent mineralocorticoid excess.
    Nunez BS; Rogerson FM; Mune T; Igarashi Y; Nakagawa Y; Phillipov G; Moudgil A; Travis LB; Palermo M; Shackleton C; White PC
    Hypertension; 1999 Oct; 34(4 Pt 1):638-42. PubMed ID: 10523339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citosine-Adenine-Repeat Microsatellite of 11β-hydroxysteroid dehydrogenase 2 Gene in Hypertensive Children.
    Valdivia C; Carvajal CA; Campino C; Allende F; Martinez-Aguayo A; Baudrand R; Vecchiola A; Lagos CF; Tapia-Castillo A; Fuentes CA; Aglony M; Solari S; Kalergis AM; García H; Owen GI; Fardella CE
    Am J Hypertens; 2016 Jan; 29(1):25-32. PubMed ID: 25907225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Urinary Exosomal HSD11B2 mRNA Expression: A Useful Novel Tool for the Diagnostic Approach of Dysfunctional 11β-HSD2-Related Hypertension.
    De Santis D; Castagna A; Danese E; Udali S; Martinelli N; Morandini F; Veneri M; Bertolone L; Olivieri O; Friso S; Pizzolo F
    Front Endocrinol (Lausanne); 2021; 12():681974. PubMed ID: 34497581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess.
    White PC; Mune T; Agarwal AK
    Endocr Rev; 1997 Feb; 18(1):135-56. PubMed ID: 9034789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis for hypertension in the "type II variant" of apparent mineralocorticoid excess.
    Li A; Tedde R; Krozowski ZS; Pala A; Li KX; Shackleton CH; Mantero F; Palermo M; Stewart PM
    Am J Hum Genet; 1998 Aug; 63(2):370-9. PubMed ID: 9683587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension.
    Ferrari P; Lovati E; Frey FJ
    J Hypertens; 2000 Mar; 18(3):241-8. PubMed ID: 10726708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apparent Mineralocorticoid Excess by a Novel Mutation and Epigenetic Modulation by HSD11B2 Promoter Methylation.
    Pizzolo F; Friso S; Morandini F; Antoniazzi F; Zaltron C; Udali S; Gandini A; Cavarzere P; Salvagno G; Giorgetti A; Speziali G; Choi SW; Olivieri O
    J Clin Endocrinol Metab; 2015 Sep; 100(9):E1234-41. PubMed ID: 26126204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and genetic characterization of 11 beta-hydroxysteroid dehydrogenase type 2 in low-renin essential hypertensives.
    Carvajal CA; Romero DG; Mosso LM; González AA; Campino C; Montero J; Fardella CE
    J Hypertens; 2005 Jan; 23(1):71-7. PubMed ID: 15643127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.